Joshua Freedman
Corporate Officer/Principal chez University of California, Los Angeles
Profil
Joshua Freedman is a Professor at the University of California, Los Angeles.
He previously worked as the Chief Medical Officer at MSI Methylation Sciences, Inc. and as a Principal at the American Psychiatric Association.
He earned a doctorate degree from Yale University.
Postes actifs de Joshua Freedman
| Sociétés | Poste | Début |
|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - |
Anciens postes connus de Joshua Freedman
| Sociétés | Poste | Fin |
|---|---|---|
American Psychiatric Association
 American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services American Psychiatric Association is the largest scientific and professional organization of psychiatrists in the world. The private company is based in Arlington, VA and has subsidiaries in the United States. APA is an organization of psychiatrists working together to ensure humane care and effective treatment for all persons with mental illness, including substance use disorders. Saul Levin has been the CEO of the company since 2013. | Corporate Officer/Principal | - |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Directeur Technique/Scientifique/R&D | - |
Formation de Joshua Freedman
| Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
American Psychiatric Association
American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services American Psychiatric Association is the largest scientific and professional organization of psychiatrists in the world. The private company is based in Arlington, VA and has subsidiaries in the United States. APA is an organization of psychiatrists working together to ensure humane care and effective treatment for all persons with mental illness, including substance use disorders. Saul Levin has been the CEO of the company since 2013. | Commercial Services |